A detailed history of Wells Fargo & Company transactions in Organon & Co. stock. As of the latest transaction made, Wells Fargo & Company holds 424,651 shares of OGN stock, worth $6.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
424,651
Previous 437,845 3.01%
Holding current value
$6.85 Million
Previous $8.23 Million 6.79%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $230,235 - $289,740
-13,194 Reduced 3.01%
424,651 $8.79 Million
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $449,476 - $613,218
-32,618 Reduced 6.93%
437,845 $8.23 Million
Q4 2023

Feb 09, 2024

SELL
$10.95 - $17.32 $3.08 Million - $4.86 Million
-280,839 Reduced 37.38%
470,463 $6.78 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $1.21 Million - $1.73 Million
-72,787 Reduced 8.83%
751,302 $13 Million
Q2 2023

Aug 15, 2023

SELL
$19.27 - $24.63 $616,620 - $788,135
-31,999 Reduced 3.74%
824,089 $17.1 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $2.69 Million - $4.03 Million
125,502 Added 17.18%
856,088 $20.1 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $901,351 - $1.11 Million
-38,668 Reduced 5.03%
730,586 $20.4 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $600,537 - $878,992
25,664 Added 3.45%
769,254 $18 Million
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $12.2 Million - $15 Million
-384,946 Reduced 34.11%
743,590 $25.1 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $2.12 Million - $2.74 Million
69,535 Added 6.57%
1,128,536 $39.4 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $16.3 Million - $21.1 Million
-567,390 Reduced 34.89%
1,059,001 $32.2 Million
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $914,041 - $1.14 Million
-31,926 Reduced 1.93%
1,626,391 $53.3 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $47.2 Million - $63 Million
1,658,317 New
1,658,317 $50.2 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.1B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.